Guidance on evaluation fees for human drugs and disinfectants: Overview

Health Canada has recently updated the Guidance document on fees for the review of human and disinfectant drug submissions and applications. The revised guidance takes effect on March 19, 2021.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Lignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue : Aperçu
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2023-02-08 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["présentations et demandes de médicaments", "présentation de médicaments pour humains et de désinfectants", "document d'orientation sur les frais", "frais d'examen", "frais d'évaluation", "aperçu du document d'orientation", "orientation révisée"], "en": ["drug submissions-and-applications", "human-drugs-and-disinfectants submission", "guidance-document on fees", "fees for review", "evaluation fees", "guidance-document overview", "revised guidance"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source